Newsletter
Newsletter Support JNS

Israeli medical-marijuana company plans Nasdaq listing

“We consider ourselves a pharma-grade cannabis leader and the major market for pharma players is Nasdaq,” said InterCure controlling shareholder Alex Rabinovitch.

Cannabis flower. Credit: Max Pixel/Creative Commons.
Cannabis flower. Credit: Max Pixel/Creative Commons.

The Israeli medical marijuana firm InterCure, whose chairman is none other than former Israeli Prime Minister Ehud Barak, has been planning to list itself on the Nasdaq stock exchange by mid-2019, controlling shareholder Alex Rabinovitch announced on Thursday.

“We consider ourselves a pharma-grade cannabis leader and the major market for pharma players is Nasdaq,” he said.

InterCure is already on the stock exchange in Tel Aviv, valued at $117 million, with its shares skyrocketing 1,300 percent so far in 2018.

The firm raised $12.1 million through a private funding round led by Rabinovitch and Gary Fegel, the founder of private-equity company GMF Capital.

It raised another $5 million last week with help from Israeli-American billionaire Adam Neumann, the CEO and co-founder of WeWork.

Approval from the Israeli government for the country’s cannabis industry to have export licenses remains pending.

The “George H.W. Bush” just arrived in the Middle East, according to CENTCOM.
“This veto is a profound failure of City Hall to demonstrate to all New Yorkers that our safety is a priority,” the groups said.
Sam Markstein, of the Republican Jewish Coalition, told JNS that Mamdani’s first veto as mayor “serves to accommodate vile antisemitic protests comes as no surprise.”
PM delayed publication of annual medical report to prevent Iranian “false propaganda” during the war.
Keir Starmer made the pledge during a solidarity visit to a synagogue that jihadists had targeted.
The terrorists fired rockets into Israel as Trump announced the extension of a tenuous pause in the fighting.